EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases: an experience from a secondary care hospital

Javedh Shareef iD, Sathvik Belagodu Sridhar, Abu Nawa Ahmad Ismail, Padma G M Rao, Rashid Ain Ur

F1000Research · 2025

DOI: 10.12688/f1000research.143186.4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift F1000Research, 2025. Verfasst von Javedh Shareef und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras Al Khaimah, 11172, United Arab…. Hauptthemen laut MEDLINE: Communicable Diseases, Hospitalization, Secondary Health Care. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polypharmacy is common among hospitalized patients with infectious infections owing to comorbidities or concurrent illnesses. This raises the likelihood of drug-drug interactions and creates uncertainty for healthcare providers. This study aimed to assess the potential drug-drug interactions (pDDIs) among hospitalized patients with infectious diseases in a secondary care hospital.

Methods

A prospective observational study was conducted in the internal medicine ward for six months. Data were collected from patient case records, and prescriptions were screened for pDDIs and classified based on the severity from a portable electronic physician information database (PEPID) resource analyzed using SPSS, version 27.0.

Results

In total, 148 patient case records were analyzed, and 549 pDDIs were identified, with 66.8% having at least one or more DDIs. The mean number of drug interactions was 3.70 ± 4.58 per prescription. The most frequently encountered drug interactions were drug combinations such as bisoprolol with atorvastatin and aspirin with tazobactam/piperacillin. Based on the severity, most pDDIs belong to the ‘moderate’ category (40.07%). Bivariate analysis showed that age, comorbidities, length of hospital stay, and the number of drugs prescribed were risk factors associated with DDIs (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Communicable DiseasesHospitalizationSecondary Health CareHumansDrug InteractionsFemaleMaleAgedMiddle AgedProspective StudiesPolypharmacyAged, 80 and overAdultRisk Factors

Stichwörter der Autor:innen

Drug interactionspatientspolypharmacyprescription drugsprevalence

Autor:innen und Institutionen

  • Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras Al Khaimah, 11172, United Arab Emirates.
  • Internal Medicine Specialist, Ibrahim Bin Hamad Obaidullah Hospital, Ras Al-Khaimah, Ras al Khaimah, 11172, United Arab Emirates.

ORCID-Profile: Javedh Shareef

Zitieren

APA

Shareef, J., Sridhar, S. B., Ahmad Ismail, A. N., Rao, P. G. M., & Ain Ur, R. (2025). Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases: an experience from a secondary care hospital. F1000Research. https://doi.org/10.12688/f1000research.143186.4

Vancouver

Shareef J, Sridhar SB, Ahmad Ismail AN, Rao PGM, Ain Ur R. Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases: an experience from a secondary care hospital. F1000Research. 2025. doi:10.12688/f1000research.143186.4

BibTeX
@article{Shareef2025,
  author = {Shareef, Javedh and Sridhar, Sathvik Belagodu and Ahmad Ismail, Abu Nawa and Rao, Padma G M and Ain Ur, Rashid},
  title = {Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases: an experience from a secondary care hospital},
  journal = {F1000Research},
  year = {2025},
  doi = {10.12688/f1000research.143186.4}
}
Kostenlos starten →